TRACON Pharmaceuticals, Inc. Gains 61.79%
Wed, Mar 13, 2024 at 07:19 PM
TRACON Pharmaceuticals, Inc. (TCON:NASDAQ) shot up at $0.63, a gain of 61.8%. On Wed, Mar 13, 2024, TCON:NASDAQ touched a New 2-Week High of $0.63. The stock appeared on our News Catalysts scanner on Tue, Mar 05, 2024 at 06:39 PM in the 'INVESTOR UPDATE' category. From Wed, Feb 28, 2024, the stock recorded 70.00% Up Days and 54.55% Green Days
About TRACON Pharmaceuticals, Inc. (TCON:NASDAQ)
TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
Top 10 Gainers:
- Laird Superfood Inc. (LSF:NYSEMKT), 104.3%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 61.79%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 59.61%
- Vroom Inc. (VRM:NASDAQ), 53.83%
- Gaxos.ai Inc Com (New) (GXAI:NASDAQ), 51.13%
- Arq Inc (ARQ:NASDAQ), 46.69%
- Kintara Therapeutics Inc. (KTRA:NASDAQ), 46.05%
- MicroCloud Hologram Inc. (HOLO:NASDAQ), 37.01%
- Li-Cycle Holdings Corp. (LICY:NYSE), 36.26%
- Airship AI Holdings Inc Com (AISP:NASDAQ), 31.63%